TW281677B - - Google Patents

Info

Publication number
TW281677B
TW281677B TW083105824A TW83105824A TW281677B TW 281677 B TW281677 B TW 281677B TW 083105824 A TW083105824 A TW 083105824A TW 83105824 A TW83105824 A TW 83105824A TW 281677 B TW281677 B TW 281677B
Authority
TW
Taiwan
Application number
TW083105824A
Other languages
Chinese (zh)
Original Assignee
Sumitomo Metal Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Metal Ind filed Critical Sumitomo Metal Ind
Application granted granted Critical
Publication of TW281677B publication Critical patent/TW281677B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW083105824A 1993-06-29 1994-06-27 TW281677B (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15874193 1993-06-29
JP15874593 1993-06-29
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体

Publications (1)

Publication Number Publication Date
TW281677B true TW281677B (enExample) 1996-07-21

Family

ID=27317735

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083105824A TW281677B (enExample) 1993-06-29 1994-06-27

Country Status (8)

Country Link
EP (1) EP0706522A1 (enExample)
JP (1) JP3338913B2 (enExample)
KR (1) KR960703405A (enExample)
AU (1) AU673754B2 (enExample)
CA (1) CA2165792A1 (enExample)
IL (1) IL110144A0 (enExample)
TW (1) TW281677B (enExample)
WO (1) WO1995001350A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
ES2172436B1 (es) * 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2003032912A2 (en) 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003296373A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7411069B2 (en) 2003-12-10 2008-08-12 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
WO2005102335A2 (en) * 2004-04-23 2005-11-03 Hypnion, Inc. Methods of treating sleep disorders
US20080214570A1 (en) * 2005-08-08 2008-09-04 Astrazeneca Ab Therapeutic Agents
WO2010013805A1 (ja) * 2008-08-01 2010-02-04 日本臓器製薬株式会社 アミノプロピリデン誘導体
JP7040802B2 (ja) * 2017-06-30 2022-03-23 株式会社ニコン 光学装置を製造する方法及び対応するシステム
JP6991315B2 (ja) 2018-04-19 2022-01-12 国立大学法人東京農工大学 サルコペニアの予防剤及び治療剤
CN113880808B (zh) * 2020-07-03 2024-12-31 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途
EP4691466A1 (en) 2023-07-25 2026-02-11 The Eye Hospital of Wenzhou Medical University Use of ptgds inhibitor in preparation of drug for treating cataracts
CN117599052A (zh) * 2023-07-25 2024-02-27 温州医科大学附属眼视光医院 Ptgds的抑制剂在制备治疗白内障药物上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
JPH03246287A (ja) * 1990-02-22 1991-11-01 Hokuriku Seiyaku Co Ltd ピペラジン誘導体
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
CA2165792A1 (en) 1995-01-12
AU673754B2 (en) 1996-11-21
JPH0770112A (ja) 1995-03-14
KR960703405A (ko) 1996-08-17
JP3338913B2 (ja) 2002-10-28
AU6983094A (en) 1995-01-24
IL110144A0 (en) 1994-10-07
EP0706522A1 (en) 1996-04-17
WO1995001350A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
DK76893D0 (enExample)
IN184070B (enExample)
FR2700330B1 (enExample)
TW281677B (enExample)
TW255885B (enExample)
IN184457B (enExample)
EP0661252A3 (enExample)
TW260722B (enExample)
ECSDI930105S (enExample)
IN183108B (enExample)
IN178859B (enExample)
DK70393D0 (enExample)
IN182323B (enExample)
ECSMU930020U (enExample)
IN177607B (enExample)
IN178258B (enExample)
ECSDI930095S (enExample)
ECSMU930023U (enExample)
ECSMU930019U (enExample)
ECSMU930021U (enExample)
IN186401B (enExample)
IN189044B (enExample)
IN180968B (enExample)
IN186235B (enExample)
IN186029B (enExample)